Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease

Summary

The purpose of this study is to evaluate the safety of APSLXR in participants with Meniere's disease or other Verigo of vestibular origin. Pharmacokinetics will also be evaluated in a small group.

Timeline

Start

2023-01

Primary completion

2025-01

Completion

2025-06

Outcome

Outcome not reported

Stopped: “Cancelled by Sponsor”

Drugs

Indications